By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – WaferGen Biosystems has entered into a $2 million loan agreement with Oxford Finance Corp., the Fremont, Calif.-based firm disclosed in a filing with the US Securities and Exchange Commission today.

The agreement was effective Dec. 7, pursuant to a secured promissory note. The note will accrue at a fixed rate of roughly 13 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.